Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tetracycline-induced aplastic anemia.

L M Lehrner, J H Cooke, R E Enck

    Southern Medical Journal
    |March 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    A patient developed severe aplastic anemia after taking tetracycline, likely due to impaired kidney function. This case highlights a rare but serious risk associated with tetracycline use in patients with renal insufficiency.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Kisspeptin-54 at high doses acutely induces testicular degeneration in adult male rats via central mechanisms.

    British journal of pharmacology·2009
    Same author

    Elevated sialic acid, but not CRP, predicts features of the metabolic syndrome independently of BMI in women.

    International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·2004
    Same author

    Managing breakthrough pain.

    The American journal of hospice & palliative care·2002
    Same author

    Parenteral opioids and cost.

    The American journal of hospice & palliative care·2002
    Same author

    Terminal sedation.

    The American journal of hospice & palliative care·2002
    Same author

    Communication.

    The American journal of hospice & palliative care·2002
    Same journal

    SMA's 6th Annual Physicians-in-Training Leadership Conference Abstract Presentations.

    Southern medical journal·2026
    Same journal

    Potential Impact of Lower Federal Loan Availability on Medical Education in Appalachia.

    Southern medical journal·2026
    Same journal

    Experiential Mentorship Skills Training: The Effect on Real-Life Mentoring.

    Southern medical journal·2026
    Same journal

    Social Pressure: How Early Social Context Shapes Career Interest in Medicine.

    Southern medical journal·2026
    Same journal

    Comparing Speed and Accuracy of Artificial Intelligence Large Language Models on the Orthopedic In-Training Examination.

    Southern medical journal·2026
    Same journal

    Don't Wait to Talk about Weight: A 2-Hour Interactive Curriculum Improves Medical Student Skills with Weight Management.

    Southern medical journal·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Hematology
    • Nephrology

    Background:

    • Antibiotic-induced adverse drug reactions can be severe and life-threatening.
    • Renal insufficiency can alter drug metabolism and excretion, increasing toxicity risk.
    • Aplastic anemia is a rare but serious condition affecting bone marrow function.

    Observation:

    • A 54-year-old man with pre-existing mild renal insufficiency was treated with gentamicin and cephalothin.
    • Following this, he received a course of tetracycline (15 gm total dose).
    • Twelve days after completing tetracycline, he developed severe aplastic anemia.

    Findings:

    • The patient's renal insufficiency likely led to bone marrow-toxic concentrations of tetracycline.
    • A temporal relationship was observed between tetracycline administration and the onset of aplastic anemia.

    Related Experiment Videos

  • The aplastic anemia was severe but ultimately reversible.

    • Implications:

    • This case suggests tetracycline can cause rare, potentially fatal aplastic anemia, especially in patients with renal impairment.
    • Clinicians should exercise caution when prescribing tetracycline to patients with reduced kidney function.
    • Monitoring for hematological toxicity is crucial in patients with risk factors for drug-induced bone marrow suppression.